As of Jul 02
| -0.15 / -0.13%|
The 2 analysts offering 12-month price forecasts for Puma Biotechnology Inc have a median target of 274.50, with a high estimate of 285.00 and a low estimate of 264.00. The median estimate represents a +144.85% increase from the last price of 112.11.
The current consensus among 4 polled investment analysts is to Buy stock in Puma Biotechnology Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.